37,586 followers
Our study assessing the role of AKT inhibitor MK2206 in Nasopharyngeal cancer http://t.co/iZmAUGTDm8
Abstract B273: Multicenter Phase II study of MK-2206 in previously treated patients (pts) with recurrent and metastatic nasopharyngeal carcinoma (NPC): Mayo Clinic Phase II Consortium (Protocol…
Overview of attention for article published in Molecular Cancer Therapeutics, November 2013